Understanding the Impact and the Critical Elements of Market Access for Biosimilars in Europe
Event Overview
The ever-changing health regulations and policies in Europe offer tremendous challenges for pharmaceutical and biotechnology companies when bringing new therapeutics to patients. The scenario becomes further complicated with the emergence of Biosimilars as a growing competitor to existing and future products.
Understanding the current market needs in a world driven by pharmacoeconomics is vital. There is a clear need to redesign the traditional approach to key stakeholders and sculpt new market access strategies to enable companies to succeed.
Why Attend?
- Understand the biosimilars market and the evolution of global policies and local options
- Identify efficient market entry strategies
- Adapt your current market access initiatives to remain successful in today’s changing market
- Gain insights that will allow you to keep ahead of the market
- Evaluate how pricing and reimbursement will be affected under the imminent reimbursement reforms
- Hear the latest updates on the regulatory changes in the US and across Europe
- Examine the various business models and clinical development strategies for biosimilars
- Network with subject matter experts and others in the UK to discuss how you can enhance your market access strategies
Who will benefit from attending?
Pharmaceutical and Marketing personnel from biopharmaceutical companies; Agency Account Directors/Managers, plus Consultants and Senior Personnel in Service Companies with responsibilities in:
- Market Access
- Marketing Strategy
- Life Cycle Management
- Pricing and Reimbursement
- Government Affairs and Public Policy
- Patient Advocacy
- Commercial and Portfolio Strategy
- Government Relations
- Health Economics and Outcomes Research
- Medical Affairs
- Brand/Therapy Heads
- Business Development.
Speakers:
Dr. Rakesh Verma – VP of Prescient Life Sciences and global expert on the Biosimilar Industry
Paul Tredwell – Head of Biopharmaceuticals, Sandoz Limited (UK)
Two leading experts will provide insight into the scientific, regulatory, economics and marketing of biosimilars and their growing impact on the pharmaceutical market.
Each speaker will provide specific reference to the evolving UK Market and the implications of Biosimilars in the development and execution of successful Market Access Strategies.
Click here to view speaker biographies.
PROGRAMME:
Registration: 6.30pm
Reception & Networking 6.30-7.00pm
Presentations & Questions 7.00-9.00pm
VENUE: The Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE
VIEW MAP AND DIRECTIONS
TICKET PRICE
This event is open to both members and non- members at a special rate of £80.00 +VAT
For further information contact the PM Society at 01403 264 898 or click below to make your online booking.
